Source: Eur Respir J 2016; 47: 994-997
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Pabary Rishi, Huang Juzheng, Kumar Sacheen, Alton Eric W.F.W., Bush Andrew, Hanna George B., Davies Jane C.. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?. Eur Respir J 2016; 47: 994-997

Member's Comments

No comment yet.

Related content which might interest you: Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Exhaled breath analysis for the detection of Streptococcus pneumoniae and Pseudomonas aeruginosa lung infections using gas chromatography – mass spectrometry: a rat model study. Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Detection of pseudomonas aeruginosa (Pa) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Source: Eur Respir J 2011; 37: 553-558 Year: 2011 Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2014; 43: 900-903 Year: 2014 DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017 Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis Source: ERJ Open Res 2015; 1: 00044-2015 Year: 2015 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003